Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrew Armstrong, MD, ScM
Duke University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Bc Cancer Agency
Vancouver, British Columbia, Canada
- Cancercare Manitoba, Med Onc, Dept Hem and Onc
Winnipeg, Manitoba, Canada
- London Health Sciences Center
London, Ontario, Canada
- Cambridge Cancer Trials Centre
Cambridge, England, United Kingdom
- the Royal Marsden Nhs
London, England, United Kingdom
- the Christie Hospital Nhs
Manchester, England, United Kingdom
- Weston Park Hospital
Sheffield, England, United Kingdom
- Churchill Hospital
Headington, Oxford, United Kingdom
- Beatson West Scotland Cancer Centre
Glasgow, Scottland, United Kingdom
- University of Chicago
Chicago, Illinois, United States
- Indiana University Melvin and Bran Simon Cancer Center
Indianapolis, Indiana, United States
- Karmanos Cancer Institute/wayne State University
Detroit, Michigan, United States
- Washington Univ in St. Louis-School of Medicine
St Louis, Missouri, United States
- Duke Univeristy Medical Center
Durham, North Carolina, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Oregon Health & Science University
Portland, Oregon, United States
- Scri
Nashville, Tennessee, United States
- the Vanderbilt Clinic, Henry-Joyce Cancer Center
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2010
- Primary completion
- 28 Feb 2015
- Completion
- 30 Apr 2015
- Last update posted
- 16 Jan 2018
- Registered enrollment
- 131
- Registry id
- NCT01108445
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.